Similarly, UZH1a, a well-characterized METTL3 inhibitor, suppresses the invasive and migratory capacities of multiple cancer cell types, including osteosarcoma and acute myeloid leukemia cells, through attenuation of m6A methylation [263]. The gene discussed is METTL3; the disease is osteosarcoma.